Efficacy and Safety of Ningmitai Capsules in Patients with Chronic Epididymitis: A Prospective, Parallel Randomized Controlled Clinical Trial

Table 2

CESI score after 2 or 4 weeks of treatment (mean ± SD).

Groups	LVX (n = 36)	NMT (n = 40)	LVX + NMT (n = 36)
CESI scores
Baseline	15.94 ± 1.87	14.53 ± 2.97	15.78 ± 2.26
2 weeks	14.92 ± 1.66	13.33 ± 3.22	12.53 ± 2.64
4 weeks	10.39 ± 2.31	10.65 ± 3.49	8.64 ± 2.15^,##

LVX, levofloxacin; NMT, Ningmitai. , compared with the LVX group. , compared with the LVX group. , compared with the LVX group. ^## compared with the NMT group.